|
Market Closed -
Nasdaq
23:00:00 26/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 3.250 USD | +0.31% |
|
+18.18% | -18.75% |
| 10-08 | X4 Pharmaceuticals Enters Up to $150 Million Term Loan Facility | MT |
| 10-08 | X4 Pharmaceuticals, Inc. Secures Up to $150 Million Senior Debt Facility with K2 HealthVentures LLC | CI |
| Market Cap | 322M 288M 267M 241M 452M 30.66B 459M 3.21B 1.27B 16.03B 1.21B 1.18B 50.77B | P/E 2026 * |
-4.87x | P/E 2027 * | -4.49x |
|---|---|---|---|---|---|
| Enterprise Value | 231M 207M 191M 173M 324M 22.02B 330M 2.3B 911M 11.52B 869M 850M 36.46B | EV / Sales 2026 * |
14.5x | EV / Sales 2027 * | 11.1x |
| Free-Float |
91.55% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| XFOR | Delayed | |
CBOE
| XFOR | Real-time |
Last Transcript: X4 Pharmaceuticals, Inc.
| 1 day | +0.31% | ||
| 1 week | +18.18% | ||
| Current month | +12.07% | ||
| 1 month | +7.97% | ||
| 3 months | -15.58% | ||
| 6 months | -20.92% | ||
| Current year | -18.75% |
| 1 week | 2.88 |  | 3.3 |
| 1 month | 2.43 | | 3.3 |
| Current year | 2.43 | | 4.83 |
| 1 year | 2.43 | | 4.83 |
| 3 years | 1.35 | | 48 |
| 5 years | 1.35 | | 185.4 |
| 10 years | 1.35 | | 717.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Adam Craig
CEO | Chief Executive Officer | 60 | - |
David Kirske
DFI | Director of Finance/CFO | 71 | 12/08/2025 |
John Volpone
PSD | President | - | 12/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Wyzga
CHM | Chairman | 71 | 01/07/2018 |
Gary Bridger
BRD | Director/Board Member | 63 | 01/10/2018 |
Murray Stewart
BRD | Director/Board Member | 65 | 29/03/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/1/26 A | Sell | Chief Financial Officer | -11,767 | 0.0125% | ||
| 8/12/26 A | Sell | Chief Operating Officer | -24,576 | 0.0261% | ||
| 8/12/26 A | Sell | Chief Executive Officer | -47,436 | 0.0503% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.31% | +18.18% | -14.47% | -85.73% | 321M | |
| +0.45% | +3.13% | +54.96% | +125.16% | 1,135B | |
| +0.94% | +4.93% | +39.86% | +78.72% | 635B | |
| +0.39% | +1.44% | +25.77% | +97.48% | 505B | |
| +1.43% | +4.31% | +46.20% | +67.12% | 378B | |
| -3.21% | -2.10% | +60.72% | +33.22% | 358B | |
| -0.41% | +2.64% | +22.48% | +49.82% | 295B | |
| +0.23% | +3.66% | +2.57% | +23.69% | 266B | |
| +1.22% | +4.63% | +52.40% | +64.85% | 237B | |
| +1.70% | +3.67% | +31.21% | +102.15% | 193B | |
| Average | +0.27% | +4.33% | +32.17% | +55.65% | 400.4B | |
| Weighted average by Cap. | +0.42% | +2.85% | +41.40% | +83.59% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.98M 14.29M 13.22M 11.97M 22.4M 1.52B 22.77M 159M 62.93M 795M 59.98M 58.69M 2.52B | 11.56M 10.34M 9.56M 8.66M 16.21M 1.1B 16.47M 115M 45.52M 575M 43.39M 42.46M 1.82B |
| Net income | -86.82M -77.63M -71.83M -65.03M -122M -8.26B -124M -864M -342M -4.32B -326M -319M -13.68B | -104M -93.25M -86.27M -78.11M -146M -9.92B -149M -1.04B -411M -5.19B -391M -383M -16.43B |
| Net Debt | -90.8M -81.19M -75.12M -68.01M -127M -8.64B -129M -904M -358M -4.52B -341M -334M -14.31B | -194M -173M -160M -145M -272M -18.46B -276M -1.93B -764M -9.65B -728M -713M -30.57B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/10/26 | $3.250 | +0.31% | 701,646 |
| 23/10/26 | $3.240 | +1.25% | 536,761 |
| 22/10/26 | $3.200 | +6.31% | 594,589 |
| 21/10/26 | $3.010 | -0.33% | 406,914 |
| 20/10/26 | $3.020 | +9.82% | 593,332 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- XFOR Stock
Select your edition
All financial news and data tailored to specific country editions
